X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1841) 1841
Book Review (319) 319
Publication (257) 257
Book Chapter (35) 35
Conference Proceeding (15) 15
Magazine Article (4) 4
Dissertation (3) 3
Book / eBook (1) 1
Data Set (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1405) 1405
humans (1249) 1249
hiv infections - drug therapy (750) 750
raltegravir (737) 737
hiv (694) 694
infectious diseases (557) 557
integrase (536) 536
raltegravir potassium (507) 507
hiv-1 - drug effects (481) 481
hiv integrase inhibitors - pharmacology (468) 468
pharmacology & pharmacy (468) 468
human immunodeficiency virus--hiv (402) 402
male (402) 402
hiv infections - virology (389) 389
antiviral agents (386) 386
virology (384) 384
female (368) 368
hiv integrase inhibitors - therapeutic use (335) 335
adult (326) 326
infection (308) 308
microbiology (299) 299
hiv-1 - genetics (297) 297
immunology (297) 297
middle aged (294) 294
antiretroviral drugs (283) 283
hiv integrase - metabolism (282) 282
antiretroviral therapy (276) 276
integrase inhibitors (273) 273
drug therapy (265) 265
mutation (256) 256
hiv-1 (253) 253
drug resistance, viral (248) 248
hiv integrase - genetics (248) 248
drug resistance (245) 245
hiv infection (243) 243
dolutegravir (237) 237
integrase inhibitor (231) 231
hiv-1 - enzymology (224) 224
hiv integrase inhibitors - chemistry (222) 222
hiv-1 integrase (222) 222
double-blind (214) 214
pyrrolidinones - therapeutic use (205) 205
chemistry, medicinal (203) 203
anti-hiv agents - therapeutic use (198) 198
pharmacokinetics (197) 197
analysis (191) 191
resistance (191) 191
anti-hiv agents - pharmacology (189) 189
in-vitro (189) 189
inhibitors (185) 185
replication (185) 185
pyrrolidinones - pharmacology (182) 182
elvitegravir (180) 180
protease inhibitors (177) 177
research (177) 177
aids (171) 171
therapy (170) 170
aids/hiv (169) 169
immunodeficiency-virus type-1 (168) 168
viral load (162) 162
treatment outcome (160) 160
biochemistry & molecular biology (159) 159
hiv integrase - chemistry (159) 159
hiv integrase inhibitors - adverse effects (152) 152
health aspects (150) 150
hiv integrase inhibitors - administration & dosage (144) 144
animals (143) 143
highly active antiretroviral therapy (139) 139
safety (138) 138
human immunodeficiency virus (132) 132
efficacy (131) 131
dna (130) 130
anti-hiv agents - administration & dosage (129) 129
article (129) 129
drug resistance, viral - genetics (128) 128
hiv integrase inhibitors - pharmacokinetics (126) 126
models, molecular (126) 126
viruses (126) 126
acquired immune deficiency syndrome--aids (124) 124
strand transfer (124) 124
drug interactions (120) 120
drug-resistance (120) 120
mutations (120) 120
hiv-1 - physiology (119) 119
virus replication - drug effects (119) 119
antiretroviral agents (118) 118
pharmacology (116) 116
drug therapy, combination (115) 115
structure-activity relationship (115) 115
pyrrolidinones - administration & dosage (114) 114
once-daily dolutegravir (113) 113
human-immunodeficiency-virus (109) 109
treatment-experienced patients (109) 109
cell line (106) 106
combination therapy (106) 106
drug design (105) 105
integrase inhibitor raltegravir (105) 105
catalytic domain (103) 103
chemistry, organic (103) 103
young adult (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1817) 1817
Spanish (42) 42
German (11) 11
Chinese (5) 5
French (4) 4
Japanese (3) 3
Russian (2) 2
Turkish (2) 2
Catalan (1) 1
Dutch (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2007, Volume 46, Issue 2, pp. 125 - 133
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9569, pp. 1261 - 1269
Summary Background Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in-vitro activity against HIV-1 strains including those resistant to... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ANTIRETROVIRAL DRUGS | THERAPY | HIV-1-INFECTED INDIVIDUALS | INFECTION | DRUG-RESISTANCE | PREVALENCE | ENFUVIRTIDE | HIV-1 | Drug Resistance, Multiple | Humans | Middle Aged | Male | HIV Integrase Inhibitors - administration & dosage | Viral Load | Oligopeptides - therapeutic use | Dose-Response Relationship, Drug | Atazanavir Sulfate | Adult | Female | Raltegravir Potassium | Organic Chemicals - administration & dosage | Pyridines - therapeutic use | Double-Blind Method | Organic Chemicals - adverse effects | Organic Chemicals - therapeutic use | Logistic Models | Treatment Outcome | Pyrrolidinones | HIV Integrase Inhibitors - adverse effects | Adolescent | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Aged | Pyridines - pharmacology | Oligopeptides - pharmacology | Viral drug resistance | Care and treatment | Dosage and administration | Drug therapy | HIV infection | Raltegravir | Design | Studies | Antiretroviral drugs | Plasma | Inhibitor drugs | Protease inhibitors | Conferences | Human immunodeficiency virus--HIV | Mortality | Gene expression | Drug resistance | Patients | RNA-directed DNA polymerase | Laboratories | Toxicity | Viruses | Genomes | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Safety | Drug dosages | Integrase | Phenotypes | Effectiveness | Proteinase inhibitors | Ribonucleic acid--RNA | Antiretroviral therapy | CD4 antigen | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Nucleosides | Index Medicus | Abridged Index Medicus
Journal Article
AIDS, ISSN 0269-9370, 11/2007, Volume 21, Issue 17, pp. 2315 - 2321
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2013, Volume 56, Issue 2, pp. 300 - 306
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2008, Volume 52, Issue 12, pp. 4228 - 4232
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2009, Volume 106, Issue 49, pp. 20865 - 20870
Raltegravir is a recently, Food and Drug Administration-approved, small-molecule drug that inhibits retroviral integrase, thereby preventing HIV DNA from... 
Lupus | Retrotransposons | Complementary DNA | HIV | DNA | Viruses | Mice | Circular DNA | Autoimmune diseases | Cells | 2-LTR circles | Lupus disease | Hemolytic anemia | Trex1 | Muring leukemia virus | SYSTEMIC-LUPUS-ERYTHEMATOSUS | muring leukemia virus | MULTIDISCIPLINARY SCIENCES | MURINE LEUKEMIA-VIRUS | AICARDI-GOUTIERES-SYNDROME | FAMILIAL CHILBLAIN LUPUS | IN-VIVO | lupus disease | MICE | MUTATIONS | EXPRESSION | hemolytic anemia | HIV Integrase Inhibitors - pharmacology | Sequence Deletion | Lupus Erythematosus, Systemic - complications | DNA, Complementary - genetics | Leukemia Virus, Murine - drug effects | Leukemia Virus, Murine - genetics | Molecular Sequence Data | DNA, Circular - genetics | Male | Phosphoproteins - metabolism | Time Factors | Base Sequence | Pyrrolidinones - pharmacology | Virus Integration - drug effects | Kidney Diseases - chemically induced | Female | Kidney Diseases - complications | Raltegravir Potassium | Amino Acid Sequence | Pyrrolidinones - adverse effects | Disease Susceptibility - complications | Autoimmune Diseases - complications | Terminal Repeat Sequences - genetics | Animals | HIV Integrase Inhibitors - adverse effects | Antibody Formation - drug effects | Viral Envelope Proteins - chemistry | Exodeoxyribonucleases - metabolism | Autoimmune Diseases - chemically induced | Development and progression | Dosage and administration | Drug therapy | Integrase inhibitors | Raltegravir | Molecules | Genomics | Leukemia | Human immunodeficiency virus--HIV | Rodents | Drugs | Glomerulonephritis | Haplotypes | Integrase | Autoantibodies | Autoimmune hemolytic anemia | Blood cells | Replication | Genomes | Food | Index Medicus | Biological Sciences
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/2008, Volume 62, Issue 5, pp. 914 - 920
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2010, Volume 53, Issue 4, pp. 456 - 463
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, pp. e40223 - e40223
Journal Article